by Darryl Leon
In Silico Technologies in Drug Target Identification and Validation addresses the challenge of testing a growing number of new potential targets and reviews currently available in silico approaches for identifying and validating these targets.
Features:
- Presents the most recent trends based on significant advances made in genomics, proteomics, and bioinformatics since the 1970s
- Examines genomic correlations between different organisms and various models that simulate disease progression in humans
- Details the components of BioIT hardware configuration and architecture requirements, a key tool for supporting in silico research
- Reviews the numerous tools, initiatives, projects, and standards for ontologies and how they can be used in the drug discovery process
- Provides examples and tables to illustrate the use of a particular technology as well as recommended books, journal articles, and Web sites for further information
Contents
Target Identification
- Pattern Matching
- Tools for Computational Protein Annotation and Functional Assignment
- The Impact of Genetic Variation on Drug Discovery and Development
- Mining of Gene Expression Data
Target Validation
- Text Mining
- Pathways and Networks
- Molecular Interactions: Learning from Protein Complexes
- In Silico siRNA Design
- Predicting Protein Subcellular Localization Using Intelligent Systems
- Three-Dimensional Structures in Target Discovery and Validation
Recent Trends
- Comparative Genomics
- Pharmacogenomics
- Target Identification and Validation Using Human Simulation Models
- Using Protein Targets for In Silico Structure-Based Drug Discovery
Computational Infrastructure
- Database Management
- BioIT Hardware Configuration
- BioIT Architecture: Software Architecture for Bioinformatics Research
- Workflows and Data Pipelines
- Ontologies
Index